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Sulfur mustard is cytotoxic to dermal ®broblasts as
well as epidermal keratinocytes. We demonstrated
that poly(ADP-ribose) polymerase (PARP) modu-
lates Fas-mediated apoptosis, and other groups and
we have shown that PARP plays a role in the modu-
lation of other types of apoptotic and necrotic cell
death. We have now utilized primary dermal ®bro-
blasts, immortalized ®broblasts, and keratinocytes
derived from PARP±/± mice and their wildtype litter-
mates (PARP+/+) to determine the contribution of
PARP to sulfur mustard toxicity. Following sulfur
mustard exposure, primary skin ®broblasts from
PARP-de®cient mice demonstrated increased inter-
nucleosomal DNA cleavage, caspase-3 processing
and activity, and annexin V positivity, compared to
those derived from PARP+/+ animals. Conversely,
propidium iodide staining, PARP cleavage patterns,
and random DNA fragmentation revealed a dose-
dependent increase in necrosis in PARP+/+ but not
PARP±/± cells. Using immortalized PARP±/± ®bro-
blasts stably transfected with the human PARP
cDNA or with empty vector alone, we show that
PARP inhibits markers of apoptosis in these cells as
well. Finally, primary keratinocytes were derived
from newborn PARP+/+ and PARP±/± mice and
immortalized with the E6 and E7 genes of human
papilloma virus. In contrast to ®broblasts, keratino-
cytes from both PARP±/± and PARP+/+ mice express
markers of apoptosis in response to sulfur mustard
exposure. The effects of PARP on the mode of cell
death in different skin cell types may determine the
severity of vesication in vivo, and thus have implica-
tions for the design of PARP inhibitors to reduce
sulfur mustard pathology. Key words: caspase-3/
poly(ADP-ribose) polymerase/sulfur mustard. J Invest
Dermatol 117:1566±1573, 2001
S
ulfur mustard [bis-(2-chloroethyl) sul®de; SM] causes
blisters in the skin via poorly understood mechanisms. We
have previously shown that SM induces markers of
terminal differentiation and apoptosis in normal human
epidermal keratinocytes (Rosenthal et al, 1998). In
addition to the direct effect of SM on keratinocytes, dermal
®broblasts are important for the vesication response. Human dermal
®broblasts may contribute to the vesication response by releasing
degradative cytosolic components extracellularly after SM expo-
sure. Lactate dehydrogenase, a cytosolic marker of necrotic cell
death, was shown to be released in a time-dependent fashion after
exposure of a dermal equivalent to 2 mM SM, suggesting a steady
leakage of cytosolic constituents after the initial exposure. Elastase
levels also increased to over 740% of those in control culture
medium 24 h after exposure (Lindsay and Upshall, 1995). In
another study, SM was shown to produce both dose- and time-
dependent cytotoxicity of a dermal equivalent, and a decreased
synthesis of ®bronectin by dermal ®broblasts. These SM-induced
dermal alterations were correlated with secondary modi®cations of
epithelial adhesion and maturation of unexposed normal human
keratinocytes (Gentilhomme et al, 1998). We have also shown
decreased levels of ®bronectin in normal human epidermal
keratinocytes exposed to SM (Rosenthal et al, 1998). In 3T3
®broblasts, total protein synthesis was reduced to < 20% of controls
24 h after SM exposure (Detheux et al, 1997). Cell viability was not
strongly affected, although the SM was used at a concentration of
only 100 mM, corresponding to the lowest dose we used in this
study.
As SM is a strong alkylating agent, its ability to induce DNA
damage via apurinic sites and endonucleolytic cleavage has been
advanced as one possible pathway leading to cell death and
vesication (Papirmeister et al, 1985). SM has in fact been shown to
induce DNA breaks in cultured cells and activate the nuclear
protein poly(ADP-ribose) polymerase (PARP) within 2 h of
exposure (Rosenthal et al, 1998; Hinshaw et al, 1999). Similar to
other agents that induce DNA strand breakage, SM-induced PARP
activation results in the poly(ADP-ribosyl)ation of a number of
nuclear proteins using nicotinamide adenine dinucleotide (NAD) as
a substrate. We have shown that topical SM exposure induces
poly(ADP-ribosyl)ation of nuclear proteins in skin grafts derived
from control human keratinocytes, but not those stably transfected
with a PARP antisense inducible vector (Rosenthal et al, 1995). A
role of PARP in SM-mediated cell death has also been investigated
in peripheral blood lymphocytes, where PARP inhibitors have
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been shown to extend the lifespan of cells treated with SM (Meier
and Johnson, 1992; Meier, 1996).
The mechanisms by which PARP may modulate SM-induced
cytotoxicity and vesication are unknown. PARP has been impli-
cated as an important regulator of both apoptosis and necrosis,
however. Induction of PARP can drastically deplete levels of
cellular NAD and adenosine triphosphate (ATP) (Wielckens et al,
1982; Alvarez et al, 1986), and the potential role for PARP in cell
death via this mechanism was ®rst proposed by Berger et al (1983;
Berger, 1985). Partial depletion of ATP by other agents has also
been shown to induce apoptosis of cultured renal epithelial cells
(Feldenberg et al, 1999). Further depletion of ATP below a
threshold level might be expected to inhibit the later events in
apoptosis, depending on the cell type and inducing agent. For
instance, Fas-induced apoptosis is completely blocked by reducing
intracellular ATP levels (Eguchi et al, 1999). In some cells, this may
re¯ect the requirement for dATP/ATP in the activation of caspase-
9 (Hu et al, 1999; Saleh et al, 1999; Zou et al, 1999). Proteolytic
cleavage of PARP was ®rst demonstrated in chemotherapy-
induced apoptosis (Kaufmann et al, 1993), and the speci®c
proteolysis of PARP is now closely associated with apoptosis in
different systems (Neamati et al, 1995; Nicholson et al, 1995;
Tewari et al, 1995). Cleavage of PARP at later stages of apoptosis
would prevent ATP from falling below this critical level.
Consistent with this idea, it was found that PARP inhibitors
prevent the SM-induced expression of necrotic markers in
lymphocytes (Meier and Millard, 1998).
Thus, the cellular response to DNA damaging agents such as SM
may depend upon the level and type of damage, as well as the cell
type. In less severely damaged cells, PARP may signal a repair
response and protect against deleterious DNA recombination
(Chatterjee et al, 1999). In more severely damaged cells, PARP
activation induces poly(ADP-ribosyl)ation of key nuclear proteins,
including p53 (Whitacre et al, 1995; Simbulan-Rosenthal et al,
1999), and a concomitant lowering of NAD and ATP levels,
resulting ultimately in cell death, the form of which (apoptosis
versus necrosis) may depend upon a number of factors, including the
time of onset of caspase activation and proteolytic cleavage of
PARP.
The PARP homozygous knockout mouse (PARP±/±) model has
been a powerful tool to analyze the roles of PARP in cell death
induced by different agents both in cultured cells and intact animals.
PARP±/± mice have now been independently generated from the
interruption of exon 2 (Wang et al, 1995), exon 4 (de Murcia et al,
1997), and, most recently, exon 1 (Masutani et al, 1999) of the
PARP gene on chromosome 1 (PARP-1). PARP±/± mice neither
express intact PARP nor exhibit signi®cant poly(ADP-ribosyl)ation
(Wang et al, 1995; de Murcia et al, 1997; Masutani et al, 1999).
Both exon 1 (Masutani et al, 1999) and exon 2 (Burkart et al, 1999;
Pieper et al, 1999) PARP±/± animals have been shown to be
resistant to streptozotocin-induced pancreatic islet cell death,
associated with NAD depletion in PARP+/+ animals. We have
also collaborated in a study that demonstrated that exon 2 PARP±/±
animals are resistant to the neurotoxin MPTP-induced parkinson-
ism (Mandir et al, 1999). Exon 2 PARP±/± animals are also more
resistant to ischemic injury (Eliasson et al, 1997; Endres et al, 1997;
Szabo et al, 1997; Zingarelli et al, 1999). In exon 2 PARP±/± cell
culture, the apoptotic response to Fas plus cycloheximide is altered,
and stable transfection of PARP cDNA reverts these cells to a
response similar to that of PARP+/+ cells (Simbulan-Rosenthal et
al, 1998). Further, expression of caspase-3-resistant PARP in exon
2 PARP±/± cells (Boulares et al, 1999; Herceg and Wang, 1999), as
well as expression of exogenous wildtype PARP (Boulares et al,
1999) in osteosarcoma cells, results in an earlier onset of both the
apoptotic (Boulares et al, 1999; Herceg and Wang, 1999) and
necrotic (Herceg and Wang, 1999) responses, a ®nding that is
consistent with an active role for PARP and poly(ADP-ribosyl)a-
tion early in apoptosis as well as necrosis. Further evidence for a
role of PARP in necrosis was determined in studies in which exon
2 PARP±/± ®broblasts were found to be more resistant to necrosis
and ATP depletion induced by the alkylating agent N-methyl-N¢-
nitro-N-nitrosoguanidine (Ha and Snyder, 1999). As yet, no
studies have been published on the effects of SM on PARP±/± versus
PARP+/+ animals or cells derived from them.
In this study, we have utilized different cell types derived from
exon 2 PARP±/± and PARP+/+ animals to determine the
contribution of PARP to apoptosis or necrosis following exposure
to SM. We found that PARP plays a role in cell death induced by
SM in primary and immortalized ®broblasts by shifting the mode of
cell death from apoptosis to necrosis. Keratinocytes, on the other
hand, express markers of apoptosis in the presence or absence of a
functional PARP-1 gene. These results indicate that (i) dermal
®broblasts and keratinocytes, which both contribute to SM
vesication, undergo different mechanisms of cell death in response
to SM, and (ii) PARP shifts the mode of cell death from apoptosis
to necrosis in dermal ®broblasts. Therefore, inhibition of PARP
may be of therapeutic value in the treatment of or prophylaxis
against SM injury, as apoptotic cell death may prevent the release of
in¯ammatory or degradative enzymes contributing to vesication or
inhibition of healing of SM-induced wounds.
MATERIALS AND METHODS
Cells Normal human epidermal keratinocytes were prepared from
human foreskins as described previously (StoÈppler et al, 1998) and
maintained in serum-free medium (SFM; Life Technologies). Normal
human epidermal keratinocytes were grown in 75 cm2 tissue culture
¯asks to 60%±80% con¯uency, and then exposed to SM diluted in SFM
to ®nal concentrations of 100 mM or 300 mM. Medium was not changed
for the duration of the experiments. Primary ®broblasts were derived
from newborn dermis as described previously (Yuspa et al, 1981).
Newborn mouse keratinocytes were derived as described previously
(Yuspa et al, 1981; Rosenthal et al, 1991), and immortalized utilizing the
E6/E7 genes of human papilloma virus 16 (HPV 16) (Sherman and
Schlegel, 1996) in the LXSN retroviral vector (Clontech, Palo Alto, CA)
as described previously (StoÈppler et al, 1998). Retrovirus-infected cells
were selected in G418, and resistant clones were passaged and analyzed
for the expression of keratins and the absence of vimentin utilizing the
antipan cytokeratin (Sigma-Aldrich, St. Louis, MO) or antivimentin
(Sigma-Aldrich) by both Western blot and immuno¯uorescent analysis.
Chemicals SM (>98% purity) was obtained from the U.S. Army
Edgewood Research, Development and Engineering Center.
Antibodies Rabbit antiserum against the p17 subunit of caspase-3
was obtained from Donald Nicholson (Merck Frosst Center for
Therapeutic Research, Montreal, Quebec, Canada). Rabbit antiserum
recognizing both full-length PARP and the 89 kDa apoptotic cleavage
product of PARP was a kind gift from Eric Ackerman (Paci®c
Northwest National Laboratory, Richland, WA). Guinea pig antisera
speci®c for poly(ADP-ribose) have been described previously (Rosenthal
et al, 1995). Antipan-keratin and antivimentin are from Sigma-Aldrich.
Immunoblot analysis For immunoblot analysis, sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) separated proteins
were transferred to nitrocellulose ®lters. Proteins were measured (DCA
protein assay; Bio-Rad, Hercules, CA) and normalized prior to gel
loading, and all ®lters were stained with Ponceau-S, in order to reduce
the possibility of loading artifacts. The details for using rabbit antiserum
to human PARP (Ding et al, 1992) and guinea pig antiserum to
poly(ADP-ribose) (Rosenthal et al, 1995) for immunoblot analysis have
been described previously in detail. Immune complexes were visualized
by electrochemiluminescence (Pierce, Rockford, IL).
Analysis of DNA fragmentation Cells were harvested and lyzed in
0.5 ml of 7 M guanidine hydrochloride. The lysate was mixed with 1 ml
of Wizard Miniprep resin (Promega, Madison, WI), incubated at room
temperature for 15 min with occasional mixing, and then centrifuged at
10,000 3 g for 5 min. The resulting pellet was resuspended in 2 ml of
washing solution [90 mM NaCl, 9 mM Tris-HCl (pH 7.4), 2.25 mM
ethylenediamine tetraacetic acid (EDTA), 55% (vol/vol) ethanol] and
drawn by vacuum through a Wizard Minicolumn (Promega) mounted
onto a vacuum manifold. The column was washed twice with 4 ml of
washing solution and dried by centrifugation over a microfuge tube at
10,000 3 g for 2 min. DNA was eluted from the column by adding
50 ml of deionized H2O, incubating at room temperature for 15 min,
and then centrifuging at 10,000 3 g for 5 min. Residual RNA in the
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eluate was removed by incubation with 10 mg of RNase A (5 Prime-3
Prime, Boulder, CO) at 37°C for 30 min. DNA samples were loaded
onto a 1.5% agarose gel in Tris-borate-EDTA buffer and subjected to
electrophoresis at 4 V per cm. DNA ladders were visualized by staining
with ethidium bromide (0.5 mg per ml) and images were captured with
the Kodak EDAS 120 (Kodak) gel documentation system.
Annexin V and propidium iodide (PI) staining, and ¯uorescence-
activated cell sorter (FACS) analysis Cells were plated in culture
plates and exposed to SM. At the indicated times after induction of
apoptosis, the cells were trypsinized, washed with ice-cold phosphate-
buffered saline (PBS), and subsequently resuspended in and incubated in
the dark with 100 ml of annexin V incubation reagent, which includes
¯uorescein isothiocyanate (FITC) conjugated annexin V (Trevigen,
Gaithersburg, MD) and PI for 15 min at room temperature. Flow
cytometric analyses were conducted on a Becton-Dickinson FACStar
Plus cytometer using a 100 mW air-cooled argon laser at 488 nm.
PARP cleavage assay The full-length cDNA clone for PARP (pcD-
12) (Alkhatib et al, 1987) was excised and ligated into the Xho I site of
pBluescript-II SK+ (Stratagene, La Jolla, CA) and then used to drive the
synthesis of PARP labeled with [35S]methionine (Dupont-NEN, Boston,
MA) by coupled T7 transcription/translation in a reticulocyte lysate
system (Promega). [35S]PARP was separated from the other constituents
by gel ®ltration chromatography on a Superdex-75 FPLC column
(Pharmacia, Peapack, NJ; 1 3 30 cm) in 10 mM HEPES/KOH
(pH 7.4), 2 mM EDTA, 0.1% (wt/vol) CHAPS, and 5 mM
dithiothreitol (DTT). Cytosolic extracts were prepared from normal
human epidermal keratinocytes by scraping PBS-washed monolayers in
10 mM HEPES/KOH (pH 7.4), 2 mM EDTA, 0.1% CHAPS, 5 mM
DTT, 1 mM phenylmethylsulfonyl ¯uoride, 10 mg per ml pepstatin A,
20 mg per ml leupeptin, and 10 mg per ml aprotinin (at 1 3 108 cells per
ml). The post 100,000g supernatant was recovered after centrifugation.
PARP cleavage activity was measured in mixtures containing 5 mg
protein from the cytosol fractions of keratinocytes. Assay mixtures also
contained puri®ed [35S]PARP (»5 3 104 cpm), 50 mM PIPES/KOH,
2 mM EDTA, 0.1% (wt/vol) CHAPS, and 5 mM DTT in a total
volume of 25 ml. Incubations were performed at 37°C for 1 h, and
terminated by the addition of 25 ml of 2 3 SDS-PAGE sample buffer
containing 4% SDS, 4% b-mercaptoethanol, 10% glycerol, 0.125 M Tris-
HCl (pH 6.8), and 0.02% bromophenol blue. Samples were resolved by
10% SDS polyacrylamide gels. Either the PARP cleavage products were
visualized by ¯uorography, or the 89 kDa cleavage product of
[35S]PARP was quanti®ed relative to the full-length PARP using a
Storm 840 PhosphorImage analyzer (Molecular Dynamics, Sunnyvale,
CA). Quanti®cation included a correction for background, as well as for
the difference in methionine residues present in the 89 kDa fragment (18
met residues) versus full-length PARP (25 met residues).
Assay of caspase-3 activity After harvesting, the cells were
resuspended in Triton X-100 lysis buffer (60 mM Tris HCl, pH 7.5,
5 mM EDTA, 10% glycerol, 2 mM sodium orthovanadate, 25 mM
sodium ¯uoride, 10 mg per ml aprotinin, 10 mg per ml leupeptin, 1 mM
AEBSF, 75 mM NaCl, 1 mg per ml pepstatin A, 1% Triton X-100) and
incubated for 30 min at 4°C. The cell lysate was centrifuged at
14,000 3 g for 15 min and the supernatant containing the postnuclear
extract was recovered. The protein concentration in the extract was
determined using the Micro BCA protein assay kit (Pierce) and then the
extract was stored at ±80°C until use. For the caspase-3 assay, 25 mg of
extract was initially resuspended up to a volume of 50 ml with Triton X-
100 lysis buffer, to which 50 ml of caspase assay buffer (10 mM HEPES,
pH 7.4, 2 mM EDTA, 0.1% CHAPS, 5 mM DTT, 10 mg per ml
aprotinin, 10 mg per ml leupeptin, 1 mM AEBSF, 1 mg per ml pepstatin
A) was added. The aliquots were preincubated at 37°C for 30 min in a
microtiter plate, and then mixed with an equal amount (100 ml) of
40 mM ¯uorescent tetrapeptide substrate speci®c for caspase-3 (Ac-
DEVD-AMC, Biomol, Plymouth Meeting, PA) in caspase assay buffer.
The plate was read immediately. Free aminomethylcoumarin (AMC),
generated as a result of cleavage of the aspartate±AMC bond, was
monitored continuously over 10 min with a Cyto¯uor 4000 ¯uorometer
(PerSeptive Biosystems, Framingham, MA) at excitation and emission
wavelengths of 360 and 460 nm, respectively. The emission from each
well was plotted against time, and linear regression analysis of the initial
velocity (slope) for each curve yielded the activity.
RESULTS
SM induces PARP-dependent necrosis in primary skin
®broblasts We have previously shown that SM induces
markers of terminal differentiation and apoptosis in normal
human epidermal keratinocytes, including the early activation and
late cleavage of PARP (Rosenthal et al, 1998). In addition to the
direct effect of SM on keratinocytes, ®broblasts are important for
the vesication response (Lindsay and Upshall, 1995; Detheux et al,
1997; Gentilhomme et al, 1998). We therefore ®rst derived primary
skin ®broblasts from PARP±/± and PARP+/+ animals. These
®broblasts were then exposed to three different doses of SM.
PARP undergoes proteolytic cleavage during chemotherapy-
induced apoptosis (Kaufmann et al, 1993). By immunoblot analysis
with epitope-speci®c antibodies, it was demonstrated that pro-
grammed cell death was accompanied by early cleavage of PARP
into 89 and 24 kDa fragments that contain the active site and the
DNA-binding domain of the enzyme, respectively. We therefore
determined whether cleavage of endogenous PARP could be
Figure 1. Exposure of primary dermal ®broblast cells derived
from PARP±/± but not PARP+/+ mice results in caspase-3
activation. Primary dermal ®broblasts were derived from newborn mice
as described in Materials and Methods. Cells were incubated for 24 h (A,
B) with the indicated concentrations of SM in keratinocyte growth
medium, or for the indicated times with 100 mM SM (C), after which
whole cell extracts were prepared and assayed for the presence of PARP
by immunoblot analysis (A), or caspase-3 activity with the speci®c
substrate DEVD-AMC (B, C). All the data in (B) and (C) are presented
as means 6 SD of three replicates of a representative experiment;
essentially the same results were obtained in three independent
experiments.
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observed in primary skin ®broblasts. Immunoblot analysis was
performed using antibodies that recognize both the full-length
(113 kDa) and 89 kDa cleavage products of PARP. Although
PARP is degraded at the higher doses of SM, no apoptotic cleavage
fragments were observed (Fig 1A). Instead, PARP was cleaved
into a 50 kDa fragment, which has been previously reported to be a
major cleavage product diagnostic of necrotic cell death (Shah et al,
1996). As expected, no immunodetectable PARP was observed in
the PARP±/± ®broblasts, con®rming the PARP±/± genotype.
The puri®cation and characterization of caspase-3, responsible
for the cleavage of PARP during apoptosis, was performed by
Nicholson et al (1995). This enzyme is composed of two subunits of
17 and 12 kDa that are derived from a common proenzyme, which
is related to interleukin-1b-converting enzyme and to CED-3, the
product of a gene required for programmed cell death in
Caenorhabditis elegans (Yuan et al, 1993). The identity of this
protease was also demonstrated by Tewari et al (1995). Twenty-
four hours after exposure, extracts were derived and analyzed for
caspase-3 activity using a ¯uorometric assay (Materials and Methods).
Whereas PARP+/+ primary ®broblasts did not exhibit SM-induced
caspase activity at any of the doses tested, PARP±/± ®broblasts
exhibited marked caspase-3 activity in response to SM at all doses
tested (Fig 1B). The greatest caspase-3 activity was observed
following treatment of PARP±/± ®broblasts with 300 mM SM.
Thus, PARP appears to inhibit apoptosis in primary dermal
®broblasts.
To determine if the difference in SM-induced caspase-3 activity
was time dependent, we performed a time course experiment.
PARP±/± or PARP+/+ primary skin ®broblasts were exposed to
300 mM SM, and then harvested at different time increments and
assayed for caspase-3 activity. Figure 1(C) shows that, at all time
points, PARP±/± cells displayed substantially more caspase-3
activity than PARP+/+ cells.
To con®rm that the difference in the mode of cell death in SM-
exposed PARP±/± and PARP+/+ skin ®broblasts was associated
with a difference in processing of procaspase-3 into its catalytically
active form, an immunoblot analysis was performed, using an
antibody speci®c for the larger subunits (p17/p20) of active caspase-
3. Figure 2(A) shows that SM induces the cleavage of procaspase-3
into the active p17/p20 forms in skin ®broblasts derived from
PARP±/± but not PARP+/+ mice.
To further establish the modes of cell death induced by SM in
PARP±/± versus PARP+/+ skin ®broblasts, we analyzed the pattern
of genomic DNA fragmentation following exposure to SM.
Following SM exposure DNA was isolated from the two different
cell types and analyzed by agarose gel electrophoresis, followed by
ethidium bromide staining. Figure 2(B) shows that DNA isolated
from SM-exposed PARP±/± primary skin ®broblasts demonstrated
the characteristic apoptotic pattern of internucleosomal cleavage,
whereas PARP+/+ ®broblast DNA appeared as a smear, character-
istic of necrosis.
An early marker of apoptosis is the exposure of phosphatidylser-
ine residues in the outer plasma membrane lea¯et (Fadok et al,
1992). The presence of these residues can be detected by their
ability to bind to annexin V (Koopman et al, 1994). To further
examine the level of apoptosis in these primary dermal ®broblasts,
we therefore exposed cells to increasing doses of SM and then
analyzed the cells for annexin V binding by FACS analysis 24 h
after SM exposure. Whereas only a small percentage of PARP+/+
primary ®broblasts were apoptotic at all doses of SM tested
(< 20%), a dose-dependent increase in the number of PARP±/±
apoptotic ®broblasts was observed, up to a maximum of 80%
(Fig 3A, left).
These results suggested that the absence of PARP shifted the
mode of cell death from necrosis to apoptosis. To verify if this is the
case, we examined the percentage of cells that were positive for PI
staining and were also annexin V negative, indicating a primarily
necrotic mode of cell death. PARP+/+ primary ®broblasts
exhibited a dose-dependent increase in the level of necrosis,
whereas PARP±/± ®broblasts underwent little necrosis at all doses
tested (Fig 3A, right). In a separate set of experiments, we
con®rmed the mode of cell death induced by SM in wildtype
and PARP±/± dermal ®broblasts, using annexin V plus PI staining.
Figure 3(B) clearly shows that the primary mode of cell death in
PARP+/+ cells is necrotic, whereas PARP±/± cells undergo
apoptosis.
In view of the absence of PARP-induced caspase-3 activity and
apoptosis in SM-exposed PARP±/± ®broblasts, we examined
whether caspase-3 was in fact responsible for SM cytotoxicity in
PARP±/± cells. We therefore preincubated PARP±/± cells with
either an inhibitor of caspase-3 (DEVD-CHO) or caspase-1
(YVAD-CHO) for 30 min prior to and during SM exposure.
PARP±/± ®broblasts that were either not pretreated or pretreated
with YVAD-CHO underwent apoptosis following SM exposure
(Fig 3C). Pretreatment with DEVD-CHO abolished the apoptotic
response, however. Thus the deletion of PARP leads to an
apoptotic mode of death that is dependent on caspase-3.
To more ®rmly establish the role of PARP in the mode of cell
death in ®broblasts, we utilized immortalized PARP±/± ®broblasts
that were stably transfected with human PARP-1 cDNA or with
empty vector alone. Western analysis shows that PARP is expressed
in immortalized wildtype ®broblasts (PARP+/+), as well as
PARP±/± ®broblasts stably transfected with the human PARP
cDNA [PARP±/± (+PARP)], but not in immortalized PARP±/±
®broblasts (Fig 4A). PARP±/± or PARP±/± (+PARP) ®broblasts
were then exposed to similar concentrations of SM and analyzed for
caspase-3 activity by performing an in vitro PARP cleavage assay
(Materials and Methods). PARP cleavage activity was induced in
PARP±/± ®broblasts at SM doses greater than 100 mM, with > 60%
cleavage observed at the highest dose of SM tested (500 mM;
Fig 4B). In contrast, the reintroduction of PARP suppressed the
in vitro PARP cleavage activity, suggesting that expression of PARP
rendered these cells more susceptible to necrosis. To further analyze
Figure 2. Exposure of primary dermal ®broblast cells derived
from PARP±/± but not PARP+/+ mice results in proteolytic
processing of procaspase-3 and internucleosomal DNA
fragmentation. Primary dermal ®broblasts were derived from newborn
mice as described in Materials and Methods. Cells were incubated for 24 h
with the indicated concentrations of SM in keratinocyte growth
medium, after which whole cell extracts (A), or DNA (B), were
prepared and assayed for proteolytic cleavage of caspase-3 by
immunoblot analysis (A) or DNA fragmentation by agarose gel
electrophoresis (B).
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caspase-3 processing, cells were exposed to SM and analyzed for the
correct processing of procaspase-3 (32 kDa) into its active form
(p17). Caspase-3 processing can clearly be observed at 300 mM and
500 mM SM in the PARP±/± cells but not in the cells stably
retransfected with PARP cDNA (Fig 4C).
To analyze the level of apoptosis after reintroduction of PARP,
annexin V plus PI staining was again utilized. Both PARP+/+ and
PARP±/± (+PARP) immortalized ®broblasts showed only low
levels of annexin V staining at all doses of SM tested (<5%;
Fig 5A). On the other hand, immortalized PARP±/± ®broblasts
demonstrated a dose-dependent increase in annexin-V-positive
cells, up to a maximum of 22%, corresponding to exposure to
500 mM SM. Conversely, dose-dependent increases in PI-positive
cells were observed in both PARP+/+ and PARP±/± (+PARP)
cells, but not in PARP±/± cells, indicating that the expression of
PARP increases the level of necrosis in immortalized ®broblasts.
SM induces apoptosis in keratinocytes in the presence or
absence of PARP We next assessed the role of PARP in the
induction of apoptosis in keratinocytes. Primary mouse
keratinocytes derived from PARP±/± animals grow poorly under
culture conditions that we normally use. In order to obtain a
suf®cient supply of keratinocytes, we derived keratinocyte clones
from PARP±/± and PARP+/+ animals following immortalization of
cells with a retrovirus that expresses both the E6 and E7 genes of
HPV 16. A number of clones were found to be both keratin-
positive and vimentin-negative by Western analysis, indicating that
these cells were in fact keratinocytes and not ®broblasts (Fig 6A,
middle and bottom panels). As with all other cells utilized in the study,
these clones were also con®rmed to be either PARP±/± or PARP+/
+ by immunoblot analysis (Fig 6A, top panel). Two different clones
of each type were then exposed to SM and caspase-3-like activity
was determined by a ¯uorometric assay as described above. All
clones demonstrated a very strong apoptotic response to SM
(Fig 6B). At the lower dose (100 mM), there was no signi®cant
difference observed in the level of caspase-3 activity induced by
SM, whereas at the higher dose (300 mM), extracts from the
PARP±/± keratinocytes showed a slightly higher activity.
Furthermore, in contrast to ®broblasts, patterns of PARP and
caspase-3 cleavage in keratinocytes indicated an apoptotic response
(Fig 6C, D). Thus, SM induces apoptosis in keratinocytes both in
the presence and in the absence of PARP.
DISCUSSION
SM vesication clearly involves both cytotoxicity and detachment of
the epidermal basal layer in vivo. Using a cell culture model in this
Figure 3. Exposure of primary dermal
®broblast cells derived from PARP±/± mice
results in a dose-dependent increase in
annexin-V-positive cells dependent upon
caspase-3 activity. Primary dermal ®broblasts
were derived from newborn mice as described in
Materials and Methods. Cells were incubated for 24
h with the indicated concentrations of SM in
keratinocyte growth medium, after which cells
were prepared and assayed for annexin V binding
plus PI staining at the doses indicated (B), or at
500 mM SM with or without the indicated caspase
inhibitors (C) by FACS analysis. Dot plots of the
results show viable (B, C, lower left quadrants), early
apoptotic (annexin-V-FITC-positive; lower right
quadrant), late apoptotic (upper right quadrant), and
necrotic (PI-positive; upper left quadrant). (A)
Percentage of cells exhibiting annexin V binding
(A, left) or PI staining (A, right) as determined by
FACS analysis. All the data in the left and right
panels of (A) are presented as means 6 SD of
three replicates of a representative experiment;
essentially the same results were obtained in three
independent experiments.
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study, we have described two potential mechanisms for SM-
induced keratinocyte basal cell death and detachment: induction of
necrosis in dermal ®broblasts and apoptosis in keratinocytes. As the
primary target of SM is the skin, we derived primary skin ®broblasts
from PARP+/+ or PARP±/± newborn animals to determine the
contribution of PARP to SM toxicity. Using quantitative
¯uorometric assays, primary skin ®broblasts from PARP-de®cient
mice showed increased caspase-3 activity compared to those
derived from PARP+/+ animals. Consistent with this observation,
in PARP±/± skin ®broblasts, SM induced proteolytic processing of
procaspase-3 to its active form, and apoptotic internucleosomal
cleavage of genomic DNA. In contrast, PARP+/+ cells displayed
characteristic markers of necrosis upon exposure to SM; PARP was
cleaved to a 50 kDa fragment, no caspase-3 processing was evident,
and genomic DNA displayed random fragmentation. Furthermore,
FACS analysis with annexin V revealed no binding to PARP+/+
cells compared to cells derived from PARP±/± animals. PI staining
also revealed that PARP shifted the mode of cell death from
apoptosis to necrosis. We also utilized immortalized PARP±/±
®broblasts transfected with vector alone or with PARP cDNA. In
vitro PARP cleavage assays as well as immunoblot analysis revealed
that only the PARP±/± cells displayed markers of apoptosis in
response to SM exposure. Primary keratinocytes were also derived
from newborn PARP+/+ and PARP±/± mice, and immortalized
with the E6 and E7 genes of HPV. In contrast to ®broblasts,
keratinocytes from both types of mice express markers of apoptosis
in response to SM exposure, consistent with our earlier studies with
normal human epidermal keratinocytes (Rosenthal et al, 1998).
SM induces both epidermal cell death and detachment from the
basal lamina in vivo. The modes of cell death of keratinocytes and
®broblasts both contribute to SM vesication as detachment may be
the result of the release of basal lamina-degrading cytosolic
components during dermal ®broblast necrosis (Lindsay and
Upshall, 1995; Gentilhomme et al, 1998), whereas keratinocyte
basal cell death is primarily due to apoptosis at the doses tested
(Rosenthal et al, 1998). The mode of cell death induced by SM
probably also affects the levels of cytokines and other factors that
determine the severity of the in¯ammatory response, as well as the
time required for healing. For example, SM-pretreated dermal
®broblasts were shown to exert inhibitory effects on the adhesion
and maturation of SM-untreated keratinocytes (Gentilhomme et al,
1998).
Although no in-depth study has been performed previously to
determine the mode of cell death induced by SM in skin ®broblasts,
this study indicates that these cells undergo necrosis at all
concentrations of SM tested (100±500 mM). Several investigators
have examined the mode of cell death induced by SM in other cell
types. SM induces an apoptotic response in HeLa cells (10±
100 mM; Sun et al, 1999), peripheral blood lymphocytes (6±
300 mM; Meier and Millard, 1998), keratinocytes (50±300 mM;
Rosenthal et al, 1998; StoÈppler et al, 1998), and endothelial cells
(< 250 mM; Dabrowska et al, 1996). A time-dependent shift to
necrosis was observed in SM-treated lymphocytes, however (Meier
and Millard, 1998), whereas markers of necrosis were observed at
higher levels of SM in endothelial cells (>500 mM; Dabrowska et al,
1996) and HeLa (1 mM; Sun et al, 1999).
Figure 4. Stable expression of PARP in immortalized PARP±/±
®broblasts eliminates SM-induced in vitro PARP cleavage activity
and inhibits processing of procaspase-3 to its active form.
Cultures of ®broblasts were analyzed for expression of PARP by
immunoblot analysis (A), and treated with the indicated concentrations
of SM (B, C). Extracts were then derived after 24 h and assayed for
caspase-3 activity, using [35S]PARP as a substrate (B), or analyzed for
caspase-3 processing by immunoblot analysis (C).
Figure 5. Stable expression of PARP in immortalized PARP±/±
®broblasts results in the elimination of a dose-dependent increase
in annexin-V-positive cells. Immortalized PARP+/+, PARP±/±, or
PARP±/± (+PARP) ®broblasts were incubated for 24 h with the
indicated concentrations of SM in keratinocyte growth medium, after
which cells were prepared and assayed for annexin V binding (A) or PI
staining (B) by FACS analysis. All the data in panels A and B are
presented as means 6 SD of three replicates of a representative
experiment; essentially the same results were obtained in three
independent experiments.
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SM is a strong bifunctional alkylating agent with a high af®nity
for DNA, and has been shown to induce DNA strand breaks and
consequently activate PARP within 2 h of exposure (Rosenthal et
al, 1998; Hinshaw et al, 1999). It is therefore likely that DNA strand
breaks and the activation of PARP play a role in the SM-induced
cell death in dermal ®broblasts and keratinocytes. The potential role
of PARP in determining the role of cell death has been examined
with SM-exposed peripheral blood lymphocytes, in which inhib-
ition of necrotic but not apoptotic markers was observed when cells
were treated with PARP inhibitors (Meier and Millard, 1998).
These results are consistent with those of this study, which indicate
that the absence of PARP in skin ®broblasts shifts the mode of cell
death from necrosis to apoptosis. Also consistent with the results of
this study, our preliminary studies in which newborn wildtype and
PARP-de®cient mice have been exposed to SM by vapor cup
indicate that PARP modulates the response of intact animals as well
(Rosenthal et al, manuscript in preparation). The mechanisms that
underlie the differences in the modes of cell death in these two cell
types remain to be elucidated, but may either be directly related to
the levels or activity of PARP in these cells, or result from other
events that regulate cellular NAD and ATP levels.
PARP inhibitors have been shown to extend the lifespan of
lymphocytes treated with SM (Meier and Johnson, 1992; Meier,
1996), and inhibitors of PARP have been reported to signi®cantly
affect the extent of apoptosis in response to other agents (Rice et al,
1992; Ghibelli et al, 1994; Monti et al, 1994; Kuo et al, 1996).
PARP may thus be an important signaling molecule for cell death
either via the lowering of NAD and/or ATP levels (Wielckens et al,
1982; Berger et al, 1983; Alvarez et al, 1986), or by poly(ADP-
ribosyl)ation of other key cellular proteins, such as p53 (Whitacre et
al, 1995; Simbulan-Rosenthal et al, 1999) and the Ca2+/Mg2+-
dependent nuclease involved in the apoptotic cleavage of DNA
(Rice et al, 1992). Depletion of cellular NAD and ATP levels via
PARP activation can contribute to either apoptotic or necrotic cell
death, as partial depletion of ATP induces apoptosis (Feldenberg et
al, 1999), whereas depletion of ATP below a threshold level blocks
the later events in apoptosis (Eguchi et al, 1999), thereby shunting
the mode of cell death to necrosis.
An understanding of the mechanisms for SM-induced cell death
in keratinocytes and dermal ®broblasts will hopefully lead to
strategies for prevention or treatment of SM vesication. This study
suggests that inhibition of PARP (upstream) or caspase-3 (down-
stream) may alter the response of the epidermis to SM. PARP
inhibitors have already been successfully employed in the preven-
tion of tissue damage in other models, including diabetes (Masiello
et al, 1985), ischemia (Endres et al, 1997; Takahashi et al, 1999), and
arthritis (Szabo et al, 1998), and may prove effective for SM as well,
either alone or in combination with caspase-3 inhibitors.
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